To evaluate clinical relevance of our findings we analyzed samples from 79 newly diagnosed AML patients for the mRNA expression of STAT3 and ICAM1. Patients expressing high levels of STAT3 showed significantly higher expression of ICAM1 (Figure 6A). This evidence concerns the gene ICAM1 and acute myeloid leukemia.